Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (#806968)
Novo Nordisk Fonden (NNF21OC0069821)
Region Zealand
Danish Ministry of Higher Education and Science
Zealand Region
Article History
Accepted: 16 April 2024
First Online: 27 April 2024
Declarations
:
: Approval for this study was granted by the Danish Data Protection Agency under the approval number REG-102–2020. The study’s retrospective design and the de-identification of patient data meant that ethics approval or written consent for participation in the research was not necessary.
: Not applicable.
: Not applicable.
: Funding parties were not involved in the design, analyses, or writing of this study.
: The authors declare no competing interests.